Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Apotex Corp.Recalls Single Lot of Carbamazepine Tablets 200 mg
Apotex Corp. has recalled a single lot of Carbamazepine Tablets 200 mg. Lot number JD2135 has been recalled because routine testing found that tablets in this lot may contain impurities. Carbamazepine is used in the treatment of epilepsy and trigeminal neuralgia. It is also sometimes used to treat mania, bipolar disorder, and other mood disorders. Carbamazepine is also sold under several different brand names. This recall alert only applies to the single lot of the generic Carbamazepine Tablets 200 mg made by Apotex. No other Carbamazepine products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm220487.htm
Learn More

FDA Warns: Nimodipine Is for Oral or Feeding Tube Use Only
The U.S. Food and Drug Administration (FDA) has issued a reminder that nimodipine should be given ONLY by mouth or through a feeding tube (nasogastric tube). This oral medication should NEVER be given by intravenous administration (an injection through the vein). Nimodipine is a medicine intended to be given in a hospital critical care setting to treat complications of the nervous system from subarachnoid hemorrhage (ruptured blood vessels in the brain). Nimodipine is only available as a capsule. The FDA continues to receive reports of intravenous nimodipine use, with serious, sometimes fatal, outcomes. Intravenous injection of nimodipine can result in death, cardiac arrest, severe drops in blood pressure, and other heart-related complications. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm220386.htm
Learn More

Date Published Title Drug Source
2010-07-30 Apotex Corp.Recalls Single Lot of Carbamazepine Tablets 200 mg Carbamazepine FDA
2010-08-05 FDA Warns: Nimodipine Is for Oral or Feeding Tube Use Only Nimodipine FDA
2010-08-05 Delay in Results From FDA's Ongoing Safety Review of Stimulant Medications used in Children with ADHD Lisdexamfetamine FDA
2010-08-11 2010-2011 Flu Vaccine: What Consumers Should Know Influenza Vaccine FDA
2010-08-11 Wellbutrin XL 150 mg: Single Lot Recalled Bupropion FDA
2010-08-11 Teva Recalls Select Lots of Amoxicillin for Oral Suspension, 400 mg/5 mL Amoxicillin FDA
2010-08-12 FDA: Aseptic Meningitis Risk with Use of Seizure Drug Lamictal Lamotrigine FDA
2010-08-15 Allergan Recalls Acuvail Eye Drops Ketorolac FDA
2010-08-15 Single Lot of ShopKo Cold/Flu Relief Multi Symptom Night Time Original Recalled Acetaminophen with Dextromethorphan and Doxylamine FDA
2010-08-16 Proctor & Gambles Recalls Select Lots of Vicks Sinex Nasal Spray Oxymetazoline FDA
2010-08-17 Companies Failed To Prove Benefits of Midodrine (ProAmantine) Midodrine Hydrochloride FDA
2010-08-20 FDA: Ongoing Safety Review of Stalevo and Possible Increased Risk of Heart Attack and Stroke Entacapone FDA
2010-09-11 FDA Sends Warning Letters to Makers of Electronic Cigarettes FDA
2010-09-16 FDA Announces New Pediatric Dosing Guidelines for Valcyte Valganciclovir FDA
2010-09-17 FDA Announces Safety Review of Actos (Pioglitazone) for Cancer Risk Glimepiride and Pioglitazone FDA
2010-09-19 FDA Issues Statement on Possible Increased Risk of Rare Bone Fractures with Long-Term Bisphosphonate Use Ibandronate Sodium FDA
2010-09-23 Avandia: Restricted Access Program To Be Developed Glimepiride and Rosiglitazone FDA
2010-09-24 Amgen Issues Epogen/Procrit Voluntary Recall: Glass Flakes Found in VIals Epoetin Alfa Manufacturer
2010-09-27 Abbott Voluntarily Recalls Certain Similac Brand Powder Infant Formulas That Did Not Meet Quality Standards Manufacturer
2010-09-28 Manufacturer Withdraws All Lots of Octagam FDA